Supporting Trials for Primary Tumor Resection in Stage IV Breast Cancer is Paramount

Harris, Elly; Barry, Mitchel; Kell, Malcolm R.

doi:10.1245/s10434-013-3098-z

Cited by 3 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…18 SEER data were collected and reported using data items and codes as documented by the North American Association of Central Cancer Registries (NAACCR). 19 Primary cancer site and histology were coded according to criteria found in the third edition of the International Classification of Diseases for Oncology (ICD-O-3).…”

Section: Cohort Definition: Surveillance Epidemiology and End Resultsmentioning

confidence: 99%

Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival

Wilhelm

Müller

Steffen

et al. 2016

Journal of Gastrointestinal Surgery

View full text Add to dashboard Cite

show abstract

Section: Cohort Definition: Surveillance Epidemiology and End Resultsmentioning

confidence: 99%

Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival

Wilhelm

Müller

Steffen

et al. 2016

Journal of Gastrointestinal Surgery

View full text Add to dashboard Cite

show abstract

Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer

et al. 2016

View full text Add to dashboard Cite

The present study-the first population-based analysis using propensity score methods-provides evidence of a favorable impact of primary tumor surgery on mortality in metastatic breast cancer patients. Most importantly, the benefit of primary tumor surgery increased over time from 1998 to 2009. Although the final results of ongoing randomized studies are awaited, currently available evidence should be discussed with metastatic breast cancer patients.

show abstract

Resection of primary lesion for patients with metastatic breast cancer: where are we now?

Hu¹,

Xu²,

Xie³

et al. 2018

Chin. Clin. Oncol.

View full text Add to dashboard Cite

It is largely unclear that whether or not surgical resection of the primary tumors could confer survival benefit among patients with metastatic breast cancer at initial presentation. We thoroughly reviewed the up-to-date evidence on surgical resection of the primary lesion in metastatic breast cancer, including comparative studies (of particular interest in risk modifiers, the type, and timing of surgical procedures), Chinese and international guidelines, as well as the progress of clinical trials. Partial modified radical mastectomy and breast-conserving surgery are by far the most common choices for patients with metastatic breast cancer. Patients with certain characteristics, for example, younger than 45 years of age or with oligo-metastasis, might benefit from the surgery. The type and timing of surgical procedures are still in debate according to the guidelines from different countries. Forthcoming evidence from the ongoing clinical trials might help close the knowledge gaps in surgical treatment for patients with metastatic breast cancer and aid the decision-making in clinical practice.

show abstract

Supporting Trials for Primary Tumor Resection in Stage IV Breast Cancer is Paramount

Cited by 3 publications

References 4 publications

Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival

Patients with Adenocarcinoma of the Small Intestine with 9 or More Regional Lymph Nodes Retrieved Have a Higher Rate of Positive Lymph Nodes and Improved Survival

Improved Survival After Primary Tumor Surgery in Metastatic Breast Cancer

Resection of primary lesion for patients with metastatic breast cancer: where are we now?

Contact Info

Product

Resources

About